Advances in the exploration of adjuvant therapy of colon cancer with Chinese medicine.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522010
- By:
- Publication type:
- Article
Works matching IS 28157125 AND DT 2022 AND VI 5
Results: 28
1
2
Research progression on immunotherapy biomarkers of peripheral blood in non-small-cell lung cancer.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522028
- By:
- Publication type:
- Article
3
Effect of Chinese herbal medicine on lung disease: an updated review.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522027
- By:
- Publication type:
- Article
4
Primary mucinous carcinoma of the thyroid: case report and review of the literature.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522023
- By:
- Publication type:
- Article
5
Pandemic adaptation in oncological management-a tertiary care radiation oncology center experience.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522004
- By:
- Publication type:
- Article
6
Meta-analysis of therapy of Kang'ai injection combined with chemotherapy in the treatment of non-small cell lung cancer.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522024
- By:
- Publication type:
- Article
7
Circ-ADAM9: a novel biomarker in human cancers.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522001
- By:
- Publication type:
- Article
8
Development history of hysteromyoma surgery with uterus preservation and introduction to each operation.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522008
- By:
- Publication type:
- Article
9
To explore the mechanism of anticancer prescription in treatment of gastric cancer based on network pharmacology and molecular docking.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522005
- By:
- Publication type:
- Article
10
A narrative review on palbociclib for hormone receptor-positive and human epidermal growth factor receptor-2 negative advanced breast cancer.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522011
- By:
- Publication type:
- Article
11
Case analysis of epithelioid hemangioendothelioma of pancreas with liver and lung involvement.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522002
- By:
- Publication type:
- Article
12
Predictive factors for the post embolization fever after transcatheter arterial chemoembolization in hepatocellular carcinoma patients: a single center study in China.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522021
- By:
- Publication type:
- Article
13
A puzzling case of differentiation syndrome mimicking SARS-CoV2 pneumonitis: a case report.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522013
- By:
- Publication type:
- Article
14
Retraction: Rare bullous pemphigoid during PD-1 inhibitor therapy: a case report. Cancer Adv. 2022;5:e22006. doi:10.53388/2022522006.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522009
- Publication type:
- Article
15
Research progress of traditional Chinese medicine monomers in intervening colorectal cancer by regulating MAPK signaling pathway.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522014
- By:
- Publication type:
- Article
16
Peer support improving the life quality of colostomy patients with colorectal cancer.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522012
- By:
- Publication type:
- Article
17
Research progress of uremic myopenia in traditional Chinese and western medicine.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522026
- By:
- Publication type:
- Article
18
Nanoemulsion for delivery of anticancer drugs.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522016
- By:
- Publication type:
- Article
19
Advancing oncology nursing practice: a vital and changing role.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522015
- By:
- Publication type:
- Article
20
The expression significance of RACGAP1 gene in hepatocellular carcinoma and its prognostic effect were analyzed based on TCGA database.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522022
- By:
- Publication type:
- Article
21
Autophagy-associated long non-coding RNA signature for lung adenocarcinoma.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522003
- By:
- Publication type:
- Article
22
Retraction: Ananas comosus loaded nanoemulsion a promising therapeutic approach for cancer. Cancer Adv. 2022;5:e22017. doi:10.53388/2022522017.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522020
- Publication type:
- Article
23
A study on the frequency of thyroid nodules and uterine fibroids in Chinese breast cancer patients.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522019
- By:
- Publication type:
- Article
24
1,3,4-Oxadiazole as an emerging telomerase inhibitor - a promising anticancer motif.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522018
- By:
- Publication type:
- Article
25
Effectiveness of total therapy in immune thrombocytopenia purpura: case series.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522007
- By:
- Publication type:
- Article
26
The perceptions and experiences of advanced cancer patients and their families in advance care planning: a systematic review and synthesis of qualitative studies.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522025
- By:
- Publication type:
- Article
27
Ananas comosus loaded nanoemulsion a promising therapeutic approach for cancer.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522017
- By:
- Publication type:
- Article
28
Rare bullous pemphigoid during PD-1 inhibitor therapy: a case report.
- Published in:
- Cancer Advances, 2022, v. 5, p. 1, doi. 10.53388/2022522006
- By:
- Publication type:
- Article